alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1   CERTIFICATION PURSUANT TO 18 U.S.C. Section 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the Annual Report of Apex Resources Group, Inc. (the Company) on Form 10-Q for the three month period ended December 31, 2007, as filed with the Securities and Exchange Commission on the date hereof (the report), I, John Rask, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2) The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  Dated this 20th day of June, 2011  /s/ John RaskJohn RaskPresident, Principal Executive Officer,
Chief Financial Officer, Principal Accounting Officer,
Secretary, Treasurer and a member of the
Board of Directors
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 2043 Reported in Senate (RS)]

                                                       Calendar No. 624
106th CONGRESS
  2d Session
                                S. 2043

  To designate the United States Post Office building located at 3101 
  West Sunflower Avenue in Santa Ana, California, as the ``Hector G. 
                    Godinez Post Office Building''.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            February 9, 2000

 Mrs. Feinstein (for herself and Mrs. Boxer) introduced the following 
      bill; which was read twice and referred to the Committee on 
                          Governmental Affairs

                             June 21, 2000

              Reported by Mr. Thompson, without amendment

_______________________________________________________________________

                                 A BILL

 
  To designate the United States Post Office building located at 3101 
  West Sunflower Avenue in Santa Ana, California, as the ``Hector G. 
                    Godinez Post Office Building''.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. DESIGNATION OF HECTOR G. GODINEZ POST OFFICE BUILDING.

    The United States Post Office building located at 3101 West 
Sunflower Avenue in Santa Ana, California, shall be known and 
designated as the ``Hector G. Godinez Post Office Building''.

SEC. 2. REFERENCES.

    Any reference in a law, regulation, map, document, paper, or other 
record of the United States to the United States Post Office building 
referred to in section 1 shall be deemed to be a reference to the 
``Hector G. Godinez Post Office Building''.
                                                       Calendar No. 624

106th CONGRESS

  2d Session

                                S. 2043

_______________________________________________________________________

                                 A BILL

  To designate the United States Post Office building located at 3101 
  West Sunflower Avenue in Santa Ana, California, as the ``Hector G. 
                    Godinez Post Office Building''.

_______________________________________________________________________

                             June 21, 2000

                       Reported without amendment
```
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         227,564
<SECURITIES>                                         0
<RECEIVABLES>                                2,952,634
<ALLOWANCES>                                   177,659
<INVENTORY>                                 16,488,120
<CURRENT-ASSETS>                            21,139,473
<PP&E>                                       4,671,245
<DEPRECIATION>                               1,111,704
<TOTAL-ASSETS>                              26,252,890
<CURRENT-LIABILITIES>                        5,995,284
<BONDS>                                     10,422,625
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         3,412
<OTHER-SE>                                   9,687,489
<TOTAL-LIABILITY-AND-EQUITY>                26,252,890
<SALES>                                     40,052,866
<TOTAL-REVENUES>                            40,052,866
<CGS>                                       25,935,829
<TOTAL-COSTS>                                3,919,615
<OTHER-EXPENSES>                               (24,861)
<LOSS-PROVISION>                               103,624
<INTEREST-EXPENSE>                             647,973
<INCOME-PRETAX>                               (425,690)
<INCOME-TAX>                                  (166,300)
<INCOME-CONTINUING>                           (259,390)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (259,390)
<EPS-PRIMARY>                                     (.08)
<EPS-DILUTED>                                     (.08)


</TABLE>
Exhibit
      32.1





CERTIFICATION
                PURSUANT TO


18
                U.S.C. SECTION 1350


ADOPTED
                PURSUANT TO


SECTION
                906 OF THE SARBANES—OXLEY ACT OF 2002








In
      connection with the Annual Report of Cable & Co Worldwide, Inc. (the
“Company”) on Form 10-KSB for the year ended September 30, 2007 as filed with
      the Securities and Exchange Commission on the date hereof (the “Report”), I,
      Gary Stein, Chief Executive Officer of the Company, certify, pursuant to 18
      U.S.C. §1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
      that to my knowledge:




(1)
            The
                Report fully complies with the requirements of Section 13(a) or 15(d),
                as
                applicable, of the Securities Exchange Act of 1934;
                and




(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company
                at the dates and for the periods
                indicated.








By:




Gary
                Stein




President
                Principal Executive Officer




Date:
      January 14,
      2008




In
      connection with the Annual Report of Cable & Co Worldwide, Inc. (the
“Company”) on Form 10-KSB for the year ended September 30, 2007 as filed with
      the Securities and Exchange Commission on the date hereof (the “Report”), I,
      John Grippo, Chief Executive Officer of the Company, certify, pursuant to 18
      U.S.C. §1350, adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
      that to my knowledge:




(1)
      The
      Report fully complies with the requirements of Section 13(a) or 15(d), as
      applicable, of the Securities Exchange Act of 1934; and




(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company
                at the dates and for the periods
                indicated.








By:




John
                Grippo




Chief
                Financial Officer (Principal Financial Officer)




Date:
                January 14, 2008




A
      signed
      original of this written statement required by Section 906, or other document
      authenticating, acknowledging, or otherwise adopting the signature that appears
      in typed form within the electronic version of this written statement required
      by Section 906, has been provided to Cable & Co Worldwide, Inc. and will be
      retained by Cable & Co Worldwide, Inc. and furnished to the Securities and
      Exchange Commission or its staff upon request.
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual
Report on Form 10-K of Salix Pharmaceuticals, Ltd. (the Company) for the period ended December 31, 2009 as filed with the Securities and Exchange Commission on or about the date hereof (the Report), I, Carolyn J. Logan,
President and Chief Executive Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the
periods presented in the Report.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------





/s/ Carolyn J. LoganCarolyn J. LoganPresident and Chief Executive OfficerMarch 9, 2010
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 1873 Introduced in Senate (IS)]

106th CONGRESS
  1st Session
                                S. 1873

   To delay the effective date of the final rule regarding the Organ 
                Procurement and Transplantation Network.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            November 5, 1999

Mr. Sessions (for himself, Mr. Hutchinson, Mr. Warner, Mr. Torricelli, 
   Mr. Mack, Mr. Shelby, Mr. Nickles, Mr. Inhofe, Mr. Thurmond, Mr. 
   Ashcroft, Mr. McConnell, Mr. Roberts, Mr. Kohl, Mr. Feingold, Mr. 
Cleland, Mr. Hollings, Mr. Breaux, Mr. Graham, Ms. Collins, Mr. Grams, 
Mr. Lautenberg, Mr. Enzi, Mr. Murkowski, Mr. Gorton, Mr. Landrieu, Mr. 
 Robb, and Mrs. Lincoln) introduced the following bill; which was read 
 twice and referred to the Committee on Health, Education, Labor, and 
                                Pensions

_______________________________________________________________________

                                 A BILL

 
   To delay the effective date of the final rule regarding the Organ 
                Procurement and Transplantation Network.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. NULLIFICATION AND REQUIREMENT FOR FURTHER RULEMAKING.

    (a) Limitation.--Notwithstanding any other provision of law, the 
final rule relating to the Organ Procurement and Transplantation 
Network, promulgated by the Secretary of Health and Human Services and 
published in the Federal Register on April 2, 1998 (63 Fed. Reg. 16296 
et. seq. adding part 121 to title 42, Code of Federal Regulations) and 
amended on October 20, 1999 (64 Fed. Reg. 56649 et seq.)), shall have 
no force or legal effect.
    (b) No Implementation or Authority.--The Secretary of Health and 
Human Services shall not implement or exercise further regulatory 
authority with respect to the Organ Procurement and Transplantation 
Network, as well as regulatory authority under sections 1102, 1106, 
1138, and 1871 of the Social Security Act (42 U.S.C. 1302, 1306, 1320b-
8, and 1395hh), prior to the date of enactment of amendments to 
reauthorize and revise part H of title III of the Public Health Service 
Act (42 U.S.C. 273 et seq.).
                                 <all>
```
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 2174 Introduced in Senate (IS)]

106th CONGRESS
  2d Session
                                S. 2174

       To suspend temporarily the duty on THQ (Toluhydroquinone).

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 2, 2000

 Mr. Thompson introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
       To suspend temporarily the duty on THQ (Toluhydroquinone).

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. TEMPORARY SUSPENSION OF DUTY.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:
      

``    9902.29.05    THQ               Free              Free              No change         On or before 12/
                     (Toluhydroquino                                                         31/2002          ''
                     ne), (CAS No.                                                                             .
                     000095-71-6)
                     (provided for
                     in subheading
                     2907.29.90)....

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
EXHIBIT 32.1
------------

                            CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection  with the Annual Report of  Peoples-Sidney  Financial  Corporation
(the  "Corporation")  on Form 10-KSB for the year ended June 30, 2005,  as filed
with the  Securities and Exchange  Commission on the date of this  Certification
(the "Report"), I, Douglas Stewart, the President and Chief Executive Officer of
the  Corporation,  certify,  pursuant  to 18 U.S.C.  Section  1350,  as  adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      1. The Report complies with the  requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and

      2.  The  information  contained  in the  Report  fairly  presents,  in all
      material  respects,  the financial  condition and results of operations of
      the Corporation.



/s/ Douglas Stewart
-------------------
Douglas Stewart, President and
Chief Executive Officer

Date:  September 28, 2005
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Mental Health Special Emphasis Panel, Brain Bank Resource Review.                    

*Date:*                         June 9, 2010.                    

*Time:*                         9 a.m. to 11 a.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call)                    

*Contact Person:*                         David W. Miller, PhD, Scientific Review Officer,  Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6140, MSC 9608, Bethesda, MD 20892-9608, 301-443-9734,                         *millerda@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS)

Dated: May 11, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-11689 Filed 5-14-10; 8:45 am]

BILLING CODE 4140-01-P
Exhibit 13.1  CERTIFICATION PURSUANT TO 18
U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002.  Each of the undersigned hereby certifies, in
accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, in his capacity as an officer of Celestica Inc.
(the Company), that the Annual Report of the Company on Form 20-F for
the period ended December 31, 2007 fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934
and that the information contained in such report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.  March 25,
  2008
  /s/ Craig
  MuhlhauserCraig H.
  MuhlhauserChief Executive
  OfficerMarch 25,
  2008
  /s/ Paul
  NicolettiPaul NicolettiChief Financial
  Officer  A signed original of this
written statement required by Section 906 has been provided to the Company
and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.
IA

106TH CONGRESS

2D SESSION S. 1836

IN THE HOUSE OF REPRESENTATIVES

MAY 2, 2000

Referred to the Committee on Commerce

AN ACT

To extend the deadline for commencement of construction

of a hydroelectric project in the State of Alabama.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

S 1836 RFH

1 SECTION 1. EXTENSION OF DEADLINE AND REINSTATE2 MENT OF LICENSE.

3 (a) IN GENERAL.—Notwithstanding the time period

4 specified in section 13 of the Federal Power Act (16

5 U.S.C. 806) that would otherwise apply to the Federal En6 ergy Regulatory Commission project numbered 7115, the

7 Commission shall, at the request of the licensee for the

8 project, in accordance with the good faith, due diligence,

9 and public interest requirements of that section and the

10 Commission’s procedures under that section, extend for 3

11 consecutive 2-year periods, the time period during which

12 the licensee is required to commence construction of the

13 project.

14 (b) APPLICABILITY.—Subsection (a) shall take effect

15 on the expiration of the period required for commencement

16 of construction of the project described in subsection (a).

17 (c) REINSTATEMENT OF EXPIRED LICENSE.—If the

18 license for the project described in subsection (a) has ex19 pired prior to the date of enactment of this Act, the Com20 mission shall reinstate the license effective as of the date

21 of its expiration and extend the time required for com22 mencement of construction of the projects for not more
3

S 1836 RFH

1 than 3 consecutive 2-year periods, the first of which shall

2 commence on the date of expiration of the license.

Passed the Senate April 13, 2000.

Attest: GARY SISCO,

Secretary.
ATTORNEY GRIEVANCE COMMISSION

OF MARYLAND

v.

CHARLES EARL WALTON *

*

*

*

*

*

*

* IN THE

COURT OF APPEALS

OF MARYLAND

Misc. Docket AG No. 0011

September Term, 2019

ORDER

UPON CONSIDERATION of the Joint Petition of the Attorney Grievance

Commission of Maryland and Respondent, Charles Earl Walton, to reprimand the

Respondent for violations of Rule s 1.3, 1.4 , and 8.4(d) of the Maryland Attorneys’ Rules

of Professional Conduct

, it is this 21st day of October 2019

ORDERED, by the Court of Appeals of Maryland, that the Respondent, Charles

Earl Walton, be reprimanded for violating Rules 1 .3, 1.4, and 8.4(d) of the Maryland Rules

of Professional Conduct.

/s/ Ro bert N. McDonald

Senior Judge
Court of Appeals

Fifth District of Texas at Dallas

MANDATE

TO THE 44TH JUDICIAL DISTRICT COURT OF DALLAS COUNTY, GREETINGS:

Before the Court of Appeals for the Fifth District of Texas, on the 29th day of July, 2014, the 

cause on appeal to revise or reverse the judgment between

BEECH STREET CORPORATION, 

Appellant

No. 05-12-01671-CV V.

BAYLOR HEALTH CARE SYSTEM, 

Appellee

On Appeal from the 44th Judicial District 

Court, Dallas County, Texas

Trial Court Cause No. DC-12-04919-B.

Opinion delivered by Justice O'Neill. 

Justices Myers and Brown participating.

was determined; and this Court made its order in these words:

In accordance with this Court’s opinion of this date, the judgment of the trial court is 

AFFIRMED.

It is ORDERED that appellee BAYLOR HEALTH CARE SYSTEM recover its costs of 

this appeal and the full amount of the trial court’s judgment from appellant BEECH STREET 

CORPORATION and from Westchester Fire Insurance Company as surety on appellant’s 

supersedeas bond.

WHEREFORE, WE COMMAND YOU to observe the order of the Court of Appeals 

for the Fifth District of Texas, in this behalf, and have it duly obeyed and executed.
–2–

WITNESS the HON. CAROLYN WRIGHT, Chief Justice of the Court of Appeals, with 

the Seal thereof affixed, at the City of Dallas, this 26th day of May, 2015.

LISA MATZ, Clerk